Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Change in Account Payables: 2013-2024

Historic Change in Account Payables for Wave Life Sciences (WVE) over the last 12 years, with Dec 2024 value amounting to $3.4 million.

  • Wave Life Sciences' Change in Account Payables rose 101.16% to $59,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 1039.22%. This contributed to the annual value of $3.4 million for FY2024, which is 190.96% up from last year.
  • According to the latest figures from FY2024, Wave Life Sciences' Change in Account Payables is $3.4 million, which was up 190.96% from -$3.8 million recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' Change in Account Payables registered a high of $9.3 million during FY2022, and its lowest value of -$6.6 million during FY2021.
  • Its 3-year average for Change in Account Payables is $3.0 million, with a median of $3.4 million in 2024.
  • In the last 5 years, Wave Life Sciences' Change in Account Payables skyrocketed by 246.33% in 2020 and then plummeted by 228.34% in 2021.
  • Over the past 5 years, Wave Life Sciences' Change in Account Payables (Yearly) stood at $5.1 million in 2020, then plummeted by 228.34% to -$6.6 million in 2021, then surged by 242.35% to $9.3 million in 2022, then plummeted by 140.23% to -$3.8 million in 2023, then skyrocketed by 190.96% to $3.4 million in 2024.